|
| Index | - | P/E | - | EPS (ttm) | -46.26 | Insider Own | 26.00% | Shs Outstand | 10.61M | Perf Week | 2.02% |
| Market Cap | 36.39M | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 8.83M | Perf Month | 7.60% |
| Income | -34.90M | PEG | - | EPS next Q | - | Inst Own | 0.20% | Short Float / Ratio | 4.50% / 0.11 | Perf Quarter | -22.37% |
| Sales | 54.50M | P/S | 0.67 | EPS this Y | - | Inst Trans | -98.58% | Short Interest | 0.40M | Perf Half Y | -29.24% |
| Book/sh | 3.34 | P/B | 1.06 | EPS next Y | - | ROA | -72.60% | Target Price | - | Perf Year | -93.71% |
| Cash/sh | 0.03 | P/C | 121.30 | EPS next 5Y | - | ROE | -772.10% | 52W Range | 1.69 - 62.25 | Perf YTD | -22.37% |
| Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | -13.20% | 52W High | -94.31% | Beta | 3.21 |
| Dividend % | - | Quick Ratio | 0.90 | Sales past 5Y | 52.80% | Gross Margin | 15.50% | 52W Low | 109.78% | ATR | 0.47 |
| Employees | 95 | Current Ratio | 1.10 | Sales Q/Q | -11.80% | Oper. Margin | 0.30% | RSI (14) | 45.51 | Volatility | 9.98% 12.53% |
| Optionable | No | Debt/Eq | 6.59 | EPS Q/Q | 31.70% | Profit Margin | -64.20% | Rel Volume | 0.07 | Prev Close | 3.61 |
| Shortable | Yes | LT Debt/Eq | 0.41 | Earnings | - | Payout | - | Avg Volume | 3.68M | Price | 3.54 |
| Recom | - | SMA20 | -2.49% | SMA50 | -19.99% | SMA200 | -47.98% | Volume | 253,031 | Change | -1.94% |
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite